The National Agency for Food and Drug Administration and Control has approved the use of the Johnson and Johnson COVID-19 vaccine in Nigeria.
The agency’s Director-General, Prof Moji Adeyeye, made this known in a statement issued on Tuesday signed by the agency’s spokesperson, Dr Abubakar Jimoh.
It read, “NAFDAC is hereby granting conditional emergency use authorisation for Janssen Covid-19 vaccine to prevent COVID’19 in people from 18 years of age
“After a thorough evaluation, the NAFDAC vaccine committee concluded that the data on the vaccine were robust and met criteria for efficacy, safety, and quality ”
According to her, data has also shown that the benefits of the vaccine outweigh its potential risk hence the need for approval.
She also said that results from a clinical trial involving people in the United States, South Africa, and Latin America countries have shown that Janssen Covid-19 vaccine was very useful in preventing Covid-19 in people from 18 years of age.
